Correlation Between Amicus Therapeutics and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Amicus Therapeutics and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Regeneron Pharmaceuticals.
Diversification Opportunities for Amicus Therapeutics and Regeneron Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Amicus and Regeneron is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Amicus Therapeutics and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 1.72 times more return on investment than Regeneron Pharmaceuticals. However, Amicus Therapeutics is 1.72 times more volatile than Regeneron Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.32 per unit of risk. If you would invest 983.00 in Amicus Therapeutics on October 9, 2024 and sell it today you would lose (53.00) from holding Amicus Therapeutics or give up 5.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amicus Therapeutics vs. Regeneron Pharmaceuticals
Performance |
| Timeline |
| Amicus Therapeutics |
| Regeneron Pharmaceuticals |
Amicus Therapeutics and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amicus Therapeutics and Regeneron Pharmaceuticals
The main advantage of trading using opposite Amicus Therapeutics and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance |